vTv Therapeutics Inc (VTVT)


Stock Price Forecast

Feb. 21, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading vTv Therapeutics Inc chart...

About the Company

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment of type 1 diabetes and inflammatory disorders, including psoriasis. vTv's development partners are pursuing additional indications in type 2 diabetes, chronic obstructive pulmonary disease (COPD), renal disease, and primary mitochondrial myopathy.

Employees

25

CEO

Stephen Holcombe

Exchange

NASDAQ

Website

www.vtvtherapeutics.com

$5M

Total Revenue

25

Employees

$47M

Market Capitalization

-3.25

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VTVT News

vTv Therapeutics, Inc. Class A

1mon ago, source: CNN

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet ...

vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

1mon ago, source: Stockhouse

HIGH POINT, N.C., March 13, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an oral adjunctive therapy to ...

VTv Therapeutics: Q4 Earnings Snapshot

1mon ago, source: The Hour

HIGH POINT, N.C. (AP) — HIGH POINT, N.C. (AP) — VTv Therapeutics Inc. (VTVT) on Wednesday reported a loss of $3.5 million in its fourth quarter. The High Point, North Carolina-based company ...

vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund

29d ago, source: ADVFN

vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type ...

VTVT vTv Therapeutics Inc.

1mon ago, source: Seeking Alpha

vTv Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases. The company’s lead drug ...

vTv Therapeutics Inc. Cl A

5d ago, source: Wall Street Journal

1 Day VTVT -2.83% DJIA 0.56% Russell 2K 0.24% Health Care/Life Sciences -1.10% ...

vTv Therapeutics Inc Class A

13d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

vTv Therapeutics Inc (VTVT)

1mon ago, source: Investing

On March 25, 2024, The Nasdaq Stock Market LLC (“Nasdaq”) notified vTv Therapeutics (NASDAQ:VTVT) that the Company had regained compliance with Nasdaq Listing Rule 5550(b)(2), ...

vTv Therapeutics Inc Class A

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

vTv Therapeutics Inc (VTVT)

28d ago, source: Investing

Bullish doji Star 5H 68 Feb 16, 2024 02:00PM ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...